American College of Cardiology

DAPA-HF and DELIVER: Treatment of severe HF across the spectrum of #LVEF with the #SGLT2 inihbitor dapagliflozin appeared to be safe and effective in reducing the risk of CV death or worsening HF. Read more: https://bit.ly/3FdaPMA #HeartFailure #JACCHF

Celebrate #InternationalWomensDay with ACC's Women in Cardiology Member Section. Don't miss out on opportunities to get involved in the Section, connect with women in cardiovascular medicine and raise your professional profile. Learn more about ACC's WIC Member Section ?? https://bit.ly/4hcWZXH

In a recent article featured in #CardiologyMag, Afif Hossain, MD, discusses present and future implications of substance use disorders, steps FITs can take to educate themselves, and more. ?? https://bit.ly/3D1wiaA #ACCFIT

A recent State-of-the-Art Review published in #JACCHF provides evidence-based recommendations on how to best optimize the care of patients with #HeartFailure through non-pharmacological strategies. Read more: https://bit.ly/3DudRLF

Various innovations in the field of preservation have helped to expand opportunities for transplant. The image below ?? highlights some of these advances. Read more about preservation techniques and new technologies in transplantation: https://bit.ly/4k9Ip6c #CardiologyMag #HeartFailure #Hearttx

Show your ACC pride by wearing ??BLUE?? on Monday, March 31 at ACC Annual Scientific Session in Chicago, IL! Join your peers from around the globe and learn the latest updates in the field with a focus on transforming cardiovascular care for all!: https://bit.ly/3ORgsRS #ACC25

HCA HealthONE Swedish is one of the latest sites to earn #ACCAccreditation’s Transcatheter Valve Certification, showing their dedication to providing high-quality care to every patient undergoing a #TAVR or #TEER procedure. The ACC celebrates additional facilities in the monthly #FindYourHeartAHome listing ?? https://bit.ly/3QBoJKW

#ACC25 Crowd-Sourced Session: Private Equity in Cardiology – Can Clinicians and Patients Thrive Here? You asked, we listened! ACC.25 will feature a dynamic session exploring the growing role of private equity in cardiology and its impact on clinicians and patient care. Led by #ACCPresident Cathleen Biga, MSN, FACC, and Edward T.A. Fry, MD, MACC, this session brings together top experts to provide key insights into the history of private equity in cardiology, the pros and cons of private equity involvement, and impacts on patient outcomes. Learn more: https://bit.ly/4gnERtO

Polypharmacy is a growing concern in CV care. Older patients, in particular, are more susceptible to adverse drug reactions (ADRs), leading to a higher risk of drug toxicity and interactions. To improve patient care, the principle of "what matters most" must be incorporated to decrease the risk of ADRs. Read more about polypharmacy in #CardiologyMag: https://bit.ly/3Xb1Gu9

Cardiologists, patients and the entire CV community spoke—American Board of Medical Specialties (ABMS) didn’t listen. We are profoundly disappointed by the decision to deny the creation of a new #CVBoard. The ABCVM Board, along with ACC and other partner societies, are reviewing options for next steps. While this is a major setback, we remain committed to supporting the needs of CV clinicians to demonstrate continued clinical competency and lifelong learning. Read more from ABCVM leadership: https://bit.ly/43gPgon